LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Other Noncurrent Assets
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Other Noncurrent Assets of -$14.00 thousand for the 3-month period ending 2017-08-27, per its 10-Q filed 2018-10-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2018-10-05
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other noncurrent assets for the quarter ending 2017-08-27 was -$14.00K, a 146.67% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other noncurrent assets for the quarter ending 2017-02-26 was -$51.00K, a 176.12% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other noncurrent assets for the quarter ending 2016-11-27 was $29.00K, a 23.68% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other noncurrent assets for the quarter ending 2016-08-28 was $30.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other noncurrent assets for fiscal 2014 was -$31.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other noncurrent assets for fiscal 2013 was -$712.00K, a 139.27% decline from fiscal 2012.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other noncurrent assets for fiscal 2012 was $1.81M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in other noncurrent assets for fiscal 2011 was -$49.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|---|
| 2017-08-27 | -$14.00K 10-Q · filed 2018-10-05 | ||||
| 2017-02-26 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | -$22.00K derived: sum of 2 quarters · filed 2018-04-05 | $8.00K 10-Q · filed 2018-04-05 | ||
| 2016-11-27 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $59.00K 10-Q · filed 2018-01-05 | |||
| 2016-08-28 | $30.00K 10-Q · filed 2017-09-28 | ||||
| 2016-02-28 | $67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07 | $105.00K derived: sum of 2 quarters · filed 2017-04-07 | $93.00K 10-Q · filed 2017-04-07 | ||
| 2015-11-29 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05 | $26.00K 10-Q · filed 2017-01-05 | |||
| 2015-08-30 | -$12.00K 10-Q · filed 2016-09-29 | ||||
| 2015-03-01 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $46.00K derived: sum of 2 quarters · filed 2016-03-30 | $255.00K 10-Q · filed 2016-03-30 | $253.00K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-11-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07 | $269.00K 10-Q · filed 2016-01-07 | $267.00K derived: sum of 3 quarters · filed 2016-01-07 | $274.00K derived: sum of 4 quarters · filed 2016-01-07 | |
| 2014-08-31 | $209.00K 10-Q · filed 2015-10-01 | $207.00K derived: sum of 2 quarters · filed 2014-10-08 | $214.00K derived: sum of 3 quarters · filed 2015-04-02 | $209.00K derived: sum of 4 quarters · filed 2015-04-02 | |
| 2014-05-25 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $5.00K derived: sum of 2 quarters · filed 2015-04-02 | $0.00 derived: sum of 3 quarters · filed 2015-04-02 | -$31.00K 10-K · filed 2014-08-01 | |
| 2014-02-23 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | $2.00K derived: sum of 2 quarters · filed 2015-04-02 | -$29.00K 10-Q · filed 2015-04-02 | -$89.00K derived: sum of 4 quarters · filed 2015-04-02 | |
| 2013-11-24 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | -$36.00K 10-Q · filed 2015-01-09 | -$96.00K derived: sum of 3 quarters · filed 2015-01-09 | -$403.00K derived: sum of 4 quarters · filed 2015-01-09 | |
| 2013-08-25 | -$31.00K 10-Q · filed 2014-10-08 | -$91.00K derived: sum of 2 quarters · filed 2014-10-08 | -$398.00K derived: sum of 3 quarters · filed 2014-10-08 | -$644.00K derived: sum of 4 quarters · filed 2014-10-08 | |
| 2013-05-26 | -$60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | -$367.00K derived: sum of 2 quarters · filed 2014-08-01 | -$613.00K derived: sum of 3 quarters · filed 2014-08-01 | -$712.00K 10-K · filed 2014-08-01 | |
| 2013-02-24 | -$307.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | -$553.00K derived: sum of 2 quarters · filed 2014-03-28 | -$652.00K 10-Q · filed 2014-03-28 | $917.00K derived: sum of 4 quarters · filed 2014-08-01 | |
| 2012-11-25 | -$246.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | -$345.00K 10-Q · filed 2014-01-03 | -$344.00K 10-Q · filed 2013-01-04 | $1.22M derived: sum of 3 quarters · filed 2014-08-01 | $1.41M derived: sum of 4 quarters · filed 2014-08-01 |
| 2012-08-26 | -$99.00K 10-Q · filed 2013-09-26 | $1.47M derived: sum of 2 quarters · filed 2014-08-01 | $1.66M derived: sum of 3 quarters · filed 2014-08-01 | $1.76M derived: sum of 4 quarters · filed 2014-08-01 | |
| 2012-05-27 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $1.76M derived: sum of 2 quarters · filed 2014-08-01 | $1.86M derived: sum of 3 quarters · filed 2014-08-01 | $1.81M 10-K · filed 2014-08-01 | |
| 2012-02-26 | $187.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $287.00K derived: sum of 2 quarters · filed 2013-04-04 | $244.00K 10-Q · filed 2013-04-04 | $233.00K derived: sum of 4 quarters · filed 2013-08-07 | |
| 2011-11-27 | $100.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | $57.00K 10-Q · filed 2013-01-04 | $46.00K derived: sum of 3 quarters · filed 2013-08-07 | ||
| 2011-08-28 | -$43.00K 10-Q/A · filed 2013-01-02 | -$54.00K derived: sum of 2 quarters · filed 2013-08-07 | |||
| 2011-05-29 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | -$49.00K 10-K · filed 2013-08-07 | |||
| 2011-02-27 | -$38.00K 10-Q · filed 2012-03-28 | ||||
| 2010-11-28 | -$24.00K 10-Q · filed 2012-01-05 | ||||
| 2010-08-29 | -$14.00K 10-Q · filed 2011-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |